- Home
- AKRO vs SAH Comparison
AKRO vs SAH Comparison
Compare AKRO & SAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- SAH
- Stock Information
- Founded
- AKRO 2017
- SAH 1997
- Country
- AKRO United States
- SAH United States
- Employees
- AKRO N/A
- SAH N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- SAH Other Specialty Stores
- Sector
- AKRO Health Care
- SAH Consumer Discretionary
- Exchange
- AKRO Nasdaq
- SAH Nasdaq
- Market Cap
- AKRO 2.2B
- SAH 2.3B
- IPO Year
- AKRO 2019
- SAH 1997
- Fundamental
- Price
- AKRO $29.53
- SAH $66.28
- Analyst Decision
- AKRO Strong Buy
- SAH Buy
- Analyst Count
- AKRO 8
- SAH 6
- Target Price
- AKRO $46.83
- SAH $68.50
- AVG Volume (30 Days)
- AKRO 535.2K
- SAH 123.2K
- Earning Date
- AKRO 11-08-2024
- SAH 02-12-2025
- Dividend Yield
- AKRO N/A
- SAH 2.10%
- EPS Growth
- AKRO N/A
- SAH N/A
- EPS
- AKRO N/A
- SAH 5.63
- Revenue
- AKRO N/A
- SAH $13,913,300,000.00
- Revenue This Year
- AKRO N/A
- SAH N/A
- Revenue Next Year
- AKRO N/A
- SAH $3.56
- P/E Ratio
- AKRO N/A
- SAH $11.92
- Revenue Growth
- AKRO N/A
- SAH N/A
- 52 Week Low
- AKRO $15.32
- SAH $47.82
- 52 Week High
- AKRO $37.00
- SAH $70.88
- Technical
- Relative Strength Index (RSI)
- AKRO 46.87
- SAH 51.77
- Support Level
- AKRO $28.45
- SAH $65.38
- Resistance Level
- AKRO $31.41
- SAH $67.65
- Average True Range (ATR)
- AKRO 1.29
- SAH 1.62
- MACD
- AKRO -0.15
- SAH -0.57
- Stochastic Oscillator
- AKRO 37.64
- SAH 14.81
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis, or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that has the potential to address the core processes underlying NASH pathogenesis.
About SAH Sonic Automotive Inc.
Sonic Automotive is one of the largest auto dealership groups in the United States. The company has 108 franchised stores in 18 states, primarily in metropolitan areas in California, Texas, and the Southeast, plus 25 EchoPark used-vehicle stores, 16 collision centers, and 13 powersports locations. The franchise stores derive revenue from new and used vehicles plus parts and collision repair, finance, insurance, and wholesale auctions. Luxury and import dealerships make up about 86% of franchise new-vehicle revenue, while Honda, BMW, Mercedes, and Toyota constitute about 58% of new-vehicle revenue. BMW is the largest brand at about 25%. 2023's revenue was $14.4 billion, with EchoPark's portion totaling $2.4 billion. Sonic bought RFJ Auto in December 2021, which added $3.2 billion in sales.